OGT Integrates NGS Automation With Hamilton STAR Systems
The integration aims to streamline library preparation for haematological malignancy research.
Updated on Oct. 16, 2026 in Biotech
Live Poll
Do you believe automation technology improves efficiency in clinical research laboratories?
Oxford Gene Technology (OGT) has integrated automated workflows into its SureSeq NGS portfolio. These systems are now compatible with Hamilton NGS STAR Line hardware to reduce manual labor.
Why it matters
Rising sample volumes have created significant throughput bottlenecks in clinical research laboratories. Automation allows these facilities to optimize resources and better meet critical turnaround time targets.
The new automated workflows are specifically engineered for compatibility with Hamilton NGS STAR Line systems. This technical integration is designed to remove manual intervention from the most labor-intensive stages of NGS library preparation.
The players
Oxford Gene Technology
This biotechnology company focuses on providing clinical research solutions, particularly in the field of haematological malignancy diagnostics.
Hamilton
Hamilton is a specialized manufacturer of laboratory automation technology and liquid handling systems used globally in clinical and research environments.
The details
The collaboration with laboratory partners and workflow specialists enables automated processing for haematological malignancy-focused panels, including the SureSeq Myeloid MRD Plus NGS Panel. By minimizing hands-on time, labs can handle higher volumes of clinical samples.
Timeline
October 16, 2026: OGT announced the new automation capabilities.
The Tech Race
The transition to automated library preparation reflects a broader industry movement away from manual, error-prone workflows toward high-throughput, integrated liquid handling. This positions OGT to remain competitive against rivals by offering end-to-end automation for complex genetic diagnostic panels.
Clinical researchers will experience improved workflow consistency and increased capacity for sample processing through the elimination of manual preparation steps. These advancements facilitate faster diagnostic results for patients undergoing genetic screening for blood-related cancers.
The takeaway
Laboratories facing high-volume throughput challenges can now rely on automated workflows to standardize complex genomic sequencing preparations. Adopting these integrated platforms helps research centers maintain quality control while significantly scaling their clinical diagnostics capacity.
Further reading
Learn more about the latest innovations in Biotech.
Source note: This article includes information reported by Labcompare.
Live Poll
Do you believe automation technology improves efficiency in clinical research laboratories?
